前收市價 | 14.42 |
開市 | 14.45 |
買盤 | 14.44 x 555100 |
賣出價 | 14.44 x 230000 |
今日波幅 | 14.26 - 14.53 |
52 週波幅 | 9.44 - 17.01 |
成交量 | |
平均成交量 | 6,798,715 |
市值 | 28.082B |
Beta 值 (5 年,每月) | 1.14 |
市盈率 (最近 12 個月) | 8.79 |
每股盈利 (最近 12 個月) | 1.64 |
業績公佈日 | 2024年10月23日 |
遠期股息及收益率 | 0.45 (3.12%) |
除息日 | 2024年5月17日 |
1 年預測目標價 | 16.60 |
(Bloomberg) -- Mankind Pharma Ltd. has picked Barclays Plc and Deutsche Bank AG to help arrange financing for its proposed 138 billion rupees ($1.6 billion) acquisition of Bharat Serums & Vaccines Ltd., according to people familiar with the matter.Most Read from BloombergTrump Risks Losing Voters He Needs With Loaded Attacks on HarrisParis Sticks to Olympics Opening Event Plans After Rail SabotageFed’s Favored Price Gauge Rises at Mild Pace, Spending Holds UpHarris Just Showed Why Trump Is So Af
(Bloomberg) -- The dent in Deutsche Bank AG’s profitability from US commercial property loans hit a new high last quarter, with the lender warning that offices are unlikely to see an improvement anytime soon.Most Read from BloombergTrump Risks Losing Voters He Needs With Loaded Attacks on HarrisHarris Just Showed Why Trump Is So Afraid of HerMarkets Tear Up Popular Trades That Reached ‘Stupid Levels’Stocks Caught in Tug of War Between Tech and Rest: Markets WrapI Changed My Mind. The Fed Needs t
Deutsche Bank's (DB) second-quarter 2024 results are impacted by an increase in expenses and a rise in provision for credit losses. The rise in commissions and fee income is a positive.